| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.01 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |